| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 103,314 | 107,486 | 113,092 | 151,123 | | Cost of Revenue | 44,597 | 48,562 | 51,496 | 73,405 | | | Gross Profit | 58,717 | 58,924 | 61,596 | 77,718 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,391 | 11,641 | 10,109 | 20,436 | | Non Recurring | 8,314 | 72 | 4,744 | 27,349 | | Others | 36,016 | 36,499 | 39,217 | 41,380 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,996 | 10,712 | 7,526 | (11,447) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,925 | 7,008 | 1,676 | (2,199) | | Earnings Before Interest And Taxes | 24,351 | 17,720 | 9,202 | (13,646) | | Interest Expense | 29,877 | 30,145 | 28,806 | 29,160 | | Income Before Tax | (5,526) | (12,425) | (19,604) | (42,806) | | Income Tax Expense | (6,554) | (2,605) | (1,816) | (5,019) | | Minority Interest | 193 | 925 | 1,982 | 10,071 | | | | Net Income From Continuing Ops | (7,768) | (7,344) | (15,777) | (68,189) | | | Non-recurring Events | | Discontinued Operations | 7,494 | 4,458 | 4,802 | 1,507 | | Extraordinary Items | (431) |
-
| 431 | (753) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,965 | (2,886) | (10,544) | (67,435) | | Preferred Stock And Other Adjustments | (4,913) | (4,824) | (4,857) | (4,857) | | | Net Income Applicable To Common Shares | ($1,948) | ($7,710) | ($15,401) | ($72,292) |
|
0.77% Nasdaq 
Income Statement
